ES8406075A1 - Un procedimiento para la preparacion de una sal de adicion de un acido bencenosulfonico de la sultamicilina. - Google Patents

Un procedimiento para la preparacion de una sal de adicion de un acido bencenosulfonico de la sultamicilina.

Info

Publication number
ES8406075A1
ES8406075A1 ES521728A ES521728A ES8406075A1 ES 8406075 A1 ES8406075 A1 ES 8406075A1 ES 521728 A ES521728 A ES 521728A ES 521728 A ES521728 A ES 521728A ES 8406075 A1 ES8406075 A1 ES 8406075A1
Authority
ES
Spain
Prior art keywords
sultamicillin
salts
benzenesulfonate salts
forms
crystalline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES521728A
Other languages
English (en)
Other versions
ES521728A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of ES8406075A1 publication Critical patent/ES8406075A1/es
Publication of ES521728A0 publication Critical patent/ES521728A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/21Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/28Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with modified 2-carboxyl group
    • C07D499/32Esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE UNA SAL DE ADICION DE UN ACIDO BENCENOSULFONICO DE LA SULTAMICILINA.CONSISTE EN HACER REACCIONAR LA BASE LIBRE DE FORMULA (II) O UNA SAL DE ADICION DE ACIDO DE LA MISMA CON UN ACIDO BENCENO-SULFONICO DE FORMULA (III) O UNA SAL DEL MISMO EN PRESENCIA DE UN DISOLVENTE COMO ACETATO DE ETILO, BUTANOL Y OTROS PARA OBTENER UNA SAL DE ADICION DE UN ACIDO BENCENOSULFONICO DE LA SULTAMILICINA DE FORMULA (I); DONDE N ES 0 A 2; X ES HIDROGENO O CLORO; Y B ES UN COMPUESTO DE FORMULA (II).TIENE APLICACION EN PEDIATRIA.
ES521728A 1982-04-23 1983-04-21 Un procedimiento para la preparacion de una sal de adicion de un acido bencenosulfonico de la sultamicilina. Granted ES521728A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/371,156 US4432987A (en) 1982-04-23 1982-04-23 Crystalline benzenesulfonate salts of sultamicillin

Publications (2)

Publication Number Publication Date
ES8406075A1 true ES8406075A1 (es) 1984-07-01
ES521728A0 ES521728A0 (es) 1984-07-01

Family

ID=23462725

Family Applications (1)

Application Number Title Priority Date Filing Date
ES521728A Granted ES521728A0 (es) 1982-04-23 1983-04-21 Un procedimiento para la preparacion de una sal de adicion de un acido bencenosulfonico de la sultamicilina.

Country Status (27)

Country Link
US (1) US4432987A (es)
EP (1) EP0092968B1 (es)
JP (1) JPS58201792A (es)
KR (1) KR860001279B1 (es)
AU (1) AU536854B2 (es)
CA (1) CA1187484A (es)
CS (1) CS235320B2 (es)
DD (1) DD209632A5 (es)
DE (1) DE3362502D1 (es)
DK (1) DK162168C (es)
EG (1) EG16412A (es)
ES (1) ES521728A0 (es)
FI (1) FI76092C (es)
GR (1) GR78582B (es)
HK (1) HK20588A (es)
HU (1) HU187068B (es)
IE (1) IE54628B1 (es)
IL (1) IL68453A (es)
NO (1) NO156202C (es)
NZ (1) NZ203988A (es)
PH (1) PH18035A (es)
PL (1) PL134978B1 (es)
PT (1) PT76587B (es)
SG (1) SG104087G (es)
SU (1) SU1138030A3 (es)
YU (1) YU43170B (es)
ZA (1) ZA832845B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6621586A (en) * 1985-11-18 1987-06-02 University Of Texas System, The Polychelating agents for image and spectral enhancement (and spectral shift)
US5336762A (en) * 1985-11-18 1994-08-09 Access Pharmaceuticals, Inc. Polychelating agents for image and spectral enhancement (and spectral shift)
KR910009271B1 (ko) * 1989-06-20 1991-11-08 김영설 1,1-디옥소페닐실라노일 옥시메틸 D-6-[α-(메틸렌아미노)페닐-아세트아미도]-페니실라네이트와 그의 파라-톨루엔술폰산염
US6111098A (en) * 1994-05-02 2000-08-29 Shionogi & Co., Ltd. Crystal of pyrrolidylthiocarbapenem derivative, lyophilized preparation containing said crystal, and process for producing the same
JP3382159B2 (ja) * 1998-08-05 2003-03-04 株式会社東芝 情報記録媒体とその再生方法及び記録方法
EP1535907A4 (en) 2002-08-29 2006-11-29 Taisho Pharmaceutical Co Ltd BENZENESULFONATE OF A 4-FLUORO-2-CYANOPYRROLIDINE DERIVATIVE
MXPA05010083A (es) * 2003-03-27 2005-11-23 Basilea Pharmaceutica Ag Cefalosporina en forma cristalina.
KR20060109922A (ko) * 2003-10-31 2006-10-23 알자 코포레이션 가바펜틴 및 프리가발린의 개선된 흡수를 위한 조성물 및제형
FR2877696B1 (fr) 2004-11-09 2009-09-18 Renault Sas Dispositif et procede d'estimation en temps reel de l'angle de debut de combustion d'un moteur a combustion interne
PL2195293T3 (pl) 2007-08-22 2014-03-31 Astrazeneca Ab Pochodne cyklopropyloamidu
UY31432A1 (es) 2007-10-26 2009-05-29 Compuestos de diarilhidantoina
AR075153A1 (es) * 2009-01-30 2011-03-16 Glaxosmithkline Llc Compuesto hidrocloruro de n-{(1s)-2-amino-1-[(3-fluorofenil)metil]etil)-5-cloro-4-(4-cloro-1-metil-1h-pirazol-5-il)-2- tiofenocarboxamida en forma cristalina, composicion farmaceitica que lo comprende, procedimiento para prepararla, su uso para preparar un medicamento util para tratar o disminuir la
TW201039825A (en) 2009-02-20 2010-11-16 Astrazeneca Ab Cyclopropyl amide derivatives 983
KR20120079054A (ko) * 2009-07-10 2012-07-11 에볼바 아게 디인 조성물
KR20130034009A (ko) * 2010-02-18 2013-04-04 아스트라제네카 아베 시클로프로필 아미드 유도체를 포함하는 고체 형태
NZ602110A (en) 2010-02-18 2014-09-26 Astrazeneca Ab Processes for making cyclopropyl amide derivatives and intermediates associated therewith
US9518004B2 (en) * 2012-12-03 2016-12-13 Kaneka Corporation Reduced coenzyme Q10 derivative and method for production thereof
KR20160051833A (ko) * 2013-09-05 2016-05-11 미쓰비시 타나베 파마 코퍼레이션 신규한 결정성 아릴알킬아민 화합물 및 그의 제조 방법
US10385078B2 (en) 2014-10-21 2019-08-20 Ariad Pharmaceuticals, Inc. Crystalline forms of 5-chloro-N4-[-2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-YL) piperidin-1-YL]phenyl}pyrimidine-2,4-diamine
CN104958318A (zh) * 2015-08-04 2015-10-07 青岛蓝盛洋医药生物科技有限责任公司 一种治疗感染性疾病的药物舒巴坦钠组合物
CA3011323A1 (en) * 2016-01-22 2017-07-27 Sandoz Ag Crystalline eravacycline bis-hydrochloride
WO2018009609A1 (en) * 2016-07-07 2018-01-11 Ironwood Pharmaceuticals, Inc. Solid forms of an sgc stimulator
WO2019089540A1 (en) * 2017-10-30 2019-05-09 Theracaine Llc Hydrophobic arenesulfonate salts
US11186556B1 (en) * 2018-10-16 2021-11-30 Celgene Corporation Salts of a thiazolidinone compound, solid forms, compositions and methods of use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4234579A (en) * 1977-06-07 1980-11-18 Pfizer Inc. Penicillanic acid 1,1-dioxides as β-lactamase inhibitors
IE49881B1 (en) * 1979-02-13 1986-01-08 Leo Pharm Prod Ltd B-lactam intermediates
ZA80796B (en) * 1979-02-13 1981-02-25 Leo Pharm Prod Ltd Chemical compounds
US4244951A (en) * 1979-05-16 1981-01-13 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
IE51516B1 (en) * 1980-10-06 1987-01-07 Leo Pharm Prod Ltd 1,1-dioxapenicillanoyloxymethyl 6-(d-alpha-amino-alpha-phenylacetamido)penicillanate napsylate
GB2084572B (en) * 1980-10-06 1984-07-11 Leo Pharm Prod Ltd 1,1-dioxopenicillanoyloxymethyl 6-(d-aphenylacetamido)penicillanate napsylate
IL64009A (en) * 1980-10-31 1984-09-30 Rech Applications Therap Crystalline 1,1-dioxopenicillanoyloxymethyl 6-(d-alpha-amino-alpha-phenylacetamido)penicillanate tosylate hydrates,their production and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
US4432987A (en) 1984-02-21
AU536854B2 (en) 1984-05-24
YU43170B (en) 1989-04-30
KR860001279B1 (ko) 1986-09-05
SG104087G (en) 1988-07-15
AU1387183A (en) 1983-11-17
CA1187484A (en) 1985-05-21
PL241553A1 (en) 1983-11-21
IL68453A (en) 1986-08-31
EP0092968A1 (en) 1983-11-02
NO156202C (no) 1987-08-19
DD209632A5 (de) 1984-05-16
JPS58201792A (ja) 1983-11-24
FI831392L (fi) 1983-10-24
NO156202B (no) 1987-05-04
DK101783D0 (da) 1983-02-28
FI76092B (fi) 1988-05-31
FI831392A0 (fi) 1983-04-22
IE54628B1 (en) 1989-12-20
JPH0119395B2 (es) 1989-04-11
HK20588A (en) 1988-03-25
PL134978B1 (en) 1985-09-30
DK162168C (da) 1992-03-02
PH18035A (en) 1985-03-06
HU187068B (en) 1985-11-28
DE3362502D1 (en) 1986-04-17
NO831430L (no) 1983-10-24
NZ203988A (en) 1986-01-24
PT76587A (en) 1983-05-01
PT76587B (en) 1986-02-27
CS235320B2 (en) 1985-05-15
EG16412A (en) 1989-03-30
GR78582B (es) 1984-09-27
YU90483A (en) 1986-04-30
EP0092968B1 (en) 1986-03-12
DK162168B (da) 1991-09-23
SU1138030A3 (ru) 1985-01-30
KR840004437A (ko) 1984-10-15
IE830926L (en) 1983-10-23
FI76092C (fi) 1988-09-09
DK101783A (da) 1983-10-24
ES521728A0 (es) 1984-07-01
IL68453A0 (en) 1983-07-31
ZA832845B (en) 1984-11-28

Similar Documents

Publication Publication Date Title
ES8406075A1 (es) Un procedimiento para la preparacion de una sal de adicion de un acido bencenosulfonico de la sultamicilina.
IL78272A0 (en) Pharmaceutical compositions comprising azolylmethyl-oxiranes for the treatment of viral diseases
ES8705387A1 (es) Un procedimiento para preparar derivados de n-aril-n-(4-piperidinil)-alcoxialquilamida
DE2963278D1 (en) Amino-pyrimidine-carbanilides, process for their preparation, medicines containing them
PT77616A (en) Process for preparing imidazolylalkylthien-2-yl-tetrahydropyri-dazines and of pharmaceutical compositions containing the same
ES8102561A1 (es) Procedimiento de preparacion de los aril-1 arilsulfonil-4 a amino-propoxi-3 1h pirazoles
IL65163A0 (en) Bispidine derivatives,their preparation and pharmaceutical compositions containing them
ZA832044B (en) Imidazolyphenyl-tetrahydropyridazines,processes for their preparation and pharmaceutical preparation containing them
ES8401944A1 (es) Procedimiento para la preparacion de derivados de acido salicilico.
DE3369983D1 (en) Isoquinoline derivatives, process for their preparation, pharmaceutical compositions containing them and their use
EP0134179A3 (en) Derivatives of 4-phenyl-4-oxo-buten-2-oic acid, their preparation, their use as medicines and compositions containing them
ES8802612A1 (es) Procedimiento para preparar derivados de benzisoselenazolilo
ES8401946A1 (es) Procedimiento para la preparacion de sulfonilureas.
DE3378120D1 (en) Thiazaspiro derivatives, process for their preparation and pharmaceutical composition
GR861646B (en) 4-amino-2-(imidazolidin-2-on-1-yl)-pyrimidino-5-carbonic acid -(n-triphthoro - methyl-phenyl)-amides for antithrombotic protection and treatment use and preparation of antithrombotically active medicines
DE3463143D1 (en) 1-0-alkyl-3-amino-propan-1.2-diol-2-0-phospholipids, process for producing the same and pharmaceutical preparations containing the same
ES8802311A1 (es) Procedimiento de preparacion de derivados del triazol y de sus sales de adicion con los acidos apropiados
ES8307778A1 (es) Procedimiento para preparar difenilbutil-1-piperazinocarboxilatos.
DE3361628D1 (en) Substituted 5-phenylthio-6-amino-pyrimidinones, process for their preparation and their use, and preparations containing these compounds
ES8203832A1 (es) Procedimiento para la preparacion de un nonapeptido
AU579997B2 (en) Iminosulphonamides and processes for the manufacture thereof, pharmaceutical preparations containing such compounds, and their use
ES2000283A6 (es) Procedimiento para preparar nuevas cetoaminas cicloalifaticas
HU901631D0 (en) Process for the preparation of thienyl-piperazine derivatives and pharmaceutical compositions containing them
ES8104173A1 (es) Procedimiento para la obtencion de compuestos hidroxi aroma-ticos